Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical materialU Abildgaard, P M Sandset, T R Andersson, et al.Acta Chirurgica Scandinavica|April 1, 1987
Plasma heparin cofactor II, protein C and antithrombin in elective surgeryT R Andersson, N S Berner, M L Larsen, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1991
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterolP M Sandset, M L Larsen, U Abildgaard, et al.Haemostasis|January 1, 1990
Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assayU Abildgaard, L Norrheim, A E Larsen, et al.Cerebrovascular Diseases (Basel, Switzerland)|February 25, 2000
Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolismT Dahl, F Kontny, C E Slagsvold, et al.The International Journal of Risk & Safety in Medicine|March 21, 2013
The long-term safety of antihyperlipidaemic drugsO R OdegaardBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Relative roles of tissue factor pathway inhibitor and antithrombin in the control of thrombogenesisU AbildgaardHaemostasis|March 1, 1993
Heparin/low molecular weight heparin and tissue factor pathway inhibitorU AbildgaardTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 17, 2001
[Olav Egeberg--hereditary antithrombin deficiency and thrombophilia]U AbildgaardTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1993
[Coma from cerebral and metabolic causes]U AbildgaardPageof 15